Mizuho downgraded Eagle Pharmaceuticals Inc. (Nasdaq: EGRX) from a Buy rating to a Neutral rating sending the stock price plummeting $4.01 to close at $40.76.
Eagle Pharmaceuticals downgraded
June 20, 2016 at 19:27 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.